Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

Authors
Type
Published Article
Journal
Targeted Oncology
1776-260X
Publisher
Springer-Verlag
Publication Date
Volume
9
Issue
3
Pages
273–277
Identifiers
DOI: 10.1007/s11523-013-0299-0
PMID: 24218035
Source
Medline

Abstract

Statistics

Seen <100 times